Cargando…

The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis

The pharmacological mechanism of curcumin against drug resistance in non-small cell lung cancer (NSCLC) remains unclear. This study aims to summarize the genes and pathways associated with curcumin action as an adjuvant therapy in NSCLC using network pharmacology, drug-likeness, pharmacokinetics, fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Han, Huang, Guirui, Zou, Jianhua, Zhu, Qianru, Liang, Zimao, Huang, Xingxing, Zhai, Xiangyang, Zhang, Ruonan, Chen, Bi, Li, Keshuai, Sui, Xinbing, Yu, Lili, Cui, Hongsheng, Wu, Qibiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586741/
https://www.ncbi.nlm.nih.gov/pubmed/36276869
http://dx.doi.org/10.1155/2022/5926609
_version_ 1784813747183812608
author Xie, Han
Huang, Guirui
Zou, Jianhua
Zhu, Qianru
Liang, Zimao
Huang, Xingxing
Zhai, Xiangyang
Zhang, Ruonan
Chen, Bi
Li, Keshuai
Sui, Xinbing
Yu, Lili
Cui, Hongsheng
Wu, Qibiao
author_facet Xie, Han
Huang, Guirui
Zou, Jianhua
Zhu, Qianru
Liang, Zimao
Huang, Xingxing
Zhai, Xiangyang
Zhang, Ruonan
Chen, Bi
Li, Keshuai
Sui, Xinbing
Yu, Lili
Cui, Hongsheng
Wu, Qibiao
author_sort Xie, Han
collection PubMed
description The pharmacological mechanism of curcumin against drug resistance in non-small cell lung cancer (NSCLC) remains unclear. This study aims to summarize the genes and pathways associated with curcumin action as an adjuvant therapy in NSCLC using network pharmacology, drug-likeness, pharmacokinetics, functional enrichment, protein-protein interaction (PPI) analysis, and molecular docking. Prognostic genes were identified from the curcumin-NSCLC intersection gene set for the following drug sensitivity analysis. Immunotherapy, chemotherapy, and targeted therapy sensitivity analyses were performed using external cohorts (GSE126044 and IMvigor210) and the CellMiner database. 94 curcumin-lung adenocarcinoma (LUAD) hub targets and 41 curcumin-lung squamous cell carcinoma (LUSC) hub targets were identified as prognostic genes. The anticancer effect of curcumin was observed in KEGG pathways involved with lung cancer, cancer therapy, and other cancers. Among the prognostic curcumin-NSCLC intersection genes, 20 LUAD and 8 LUSC genes were correlated with immunotherapy sensitivity in the GSE126044 NSCLC cohort; 30 LUAD and 13 LUSC genes were associated with immunotherapy sensitivity in the IMvigor210 cohort; and 12 LUAD and 13 LUSC genes were related to chemosensitivity in the CellMiner database. Moreover, 3 LUAD and 5 LUSC genes were involved in the response to targeted therapy in the CellMiner database. Curcumin regulates drug sensitivity in NSCLC by interacting with cell cycle, NF-kappa B, MAPK, Th17 cell differentiation signaling pathways, etc. Curcumin in combination with immunotherapy, chemotherapy, or targeted drugs has the potential to be effective for drug-resistant NSCLC. The findings of our study reveal the relevant key signaling pathways and targets of curcumin as an adjuvant therapy in the treatment of NSCLC, thus providing pharmacological evidence for further experimental research.
format Online
Article
Text
id pubmed-9586741
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95867412022-10-22 The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis Xie, Han Huang, Guirui Zou, Jianhua Zhu, Qianru Liang, Zimao Huang, Xingxing Zhai, Xiangyang Zhang, Ruonan Chen, Bi Li, Keshuai Sui, Xinbing Yu, Lili Cui, Hongsheng Wu, Qibiao Evid Based Complement Alternat Med Research Article The pharmacological mechanism of curcumin against drug resistance in non-small cell lung cancer (NSCLC) remains unclear. This study aims to summarize the genes and pathways associated with curcumin action as an adjuvant therapy in NSCLC using network pharmacology, drug-likeness, pharmacokinetics, functional enrichment, protein-protein interaction (PPI) analysis, and molecular docking. Prognostic genes were identified from the curcumin-NSCLC intersection gene set for the following drug sensitivity analysis. Immunotherapy, chemotherapy, and targeted therapy sensitivity analyses were performed using external cohorts (GSE126044 and IMvigor210) and the CellMiner database. 94 curcumin-lung adenocarcinoma (LUAD) hub targets and 41 curcumin-lung squamous cell carcinoma (LUSC) hub targets were identified as prognostic genes. The anticancer effect of curcumin was observed in KEGG pathways involved with lung cancer, cancer therapy, and other cancers. Among the prognostic curcumin-NSCLC intersection genes, 20 LUAD and 8 LUSC genes were correlated with immunotherapy sensitivity in the GSE126044 NSCLC cohort; 30 LUAD and 13 LUSC genes were associated with immunotherapy sensitivity in the IMvigor210 cohort; and 12 LUAD and 13 LUSC genes were related to chemosensitivity in the CellMiner database. Moreover, 3 LUAD and 5 LUSC genes were involved in the response to targeted therapy in the CellMiner database. Curcumin regulates drug sensitivity in NSCLC by interacting with cell cycle, NF-kappa B, MAPK, Th17 cell differentiation signaling pathways, etc. Curcumin in combination with immunotherapy, chemotherapy, or targeted drugs has the potential to be effective for drug-resistant NSCLC. The findings of our study reveal the relevant key signaling pathways and targets of curcumin as an adjuvant therapy in the treatment of NSCLC, thus providing pharmacological evidence for further experimental research. Hindawi 2022-10-14 /pmc/articles/PMC9586741/ /pubmed/36276869 http://dx.doi.org/10.1155/2022/5926609 Text en Copyright © 2022 Han Xie et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xie, Han
Huang, Guirui
Zou, Jianhua
Zhu, Qianru
Liang, Zimao
Huang, Xingxing
Zhai, Xiangyang
Zhang, Ruonan
Chen, Bi
Li, Keshuai
Sui, Xinbing
Yu, Lili
Cui, Hongsheng
Wu, Qibiao
The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis
title The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis
title_full The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis
title_fullStr The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis
title_full_unstemmed The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis
title_short The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis
title_sort pharmacological mechanism of curcumin against drug resistance in non-small cell lung cancer: findings of network pharmacology and bioinformatics analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586741/
https://www.ncbi.nlm.nih.gov/pubmed/36276869
http://dx.doi.org/10.1155/2022/5926609
work_keys_str_mv AT xiehan thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT huangguirui thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT zoujianhua thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT zhuqianru thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT liangzimao thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT huangxingxing thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT zhaixiangyang thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT zhangruonan thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT chenbi thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT likeshuai thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT suixinbing thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT yulili thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT cuihongsheng thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT wuqibiao thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT xiehan pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT huangguirui pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT zoujianhua pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT zhuqianru pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT liangzimao pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT huangxingxing pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT zhaixiangyang pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT zhangruonan pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT chenbi pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT likeshuai pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT suixinbing pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT yulili pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT cuihongsheng pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis
AT wuqibiao pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis